Literature DB >> 20116856

Requirement for ubiquitin conjugation and 26S proteasome activity at an early stage in V(D)J recombination.

Anamika Bhattacharyya1, Jessica M Jones.   

Abstract

V(D)J recombination, the process that rearranges gene segments to assemble mature antigen receptor genes, relies on a recombinase comprising the RAG1 and RAG2 proteins. RAG1 is a multi-functional enzyme including DNA binding and cleavage as well as ubiquitin ligase activities, all of which appear to contribute to its role in recombination. Here we demonstrate that components of the ubiquitin conjugation machinery and the 26S proteasome are required for an early step in V(D)J recombination. Inhibitors of the 26S proteasome and ubiquitin activating enzyme (E1) blocked both chromosomal and extra-chromosomal recombination when added 1h following transfection/induction, but they had no effect when added 16 h later. There was no effect on expression of RAG1, and recombination did not require transit through the cell cycle, confirming that inhibition was not due to an indirect effect on cell cycle arrest or protein expression. Experiments in which RAG1 translation was blocked with cyclohexamide after 16 h of expression indicated that many active recombination complexes were formed within this window, although recombination products continued to accumulate for 48 h. These data suggest that ubiquitin-dependent degradation is an early step in complex assembly or activation, and are consistent with our previous hypothesis that degradation of a negative regulator is required to trigger recombination. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116856      PMCID: PMC2830333          DOI: 10.1016/j.molimm.2010.01.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  41 in total

1.  Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development.

Authors:  Steven T Kosak; Jane A Skok; Kay L Medina; Roy Riblet; Michelle M Le Beau; Amanda G Fisher; Harinder Singh
Journal:  Science       Date:  2002-04-05       Impact factor: 47.728

Review 2.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

3.  RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO.

Authors:  Carsten Hoege; Boris Pfander; George-Lucian Moldovan; George Pyrowolakis; Stefan Jentsch
Journal:  Nature       Date:  2002-09-12       Impact factor: 49.962

4.  Complementation of V(D)J recombination deficiency in RAG-1(-/-) B cells reveals a requirement for novel elements in the N-terminus of RAG-1.

Authors:  C A Roman; S R Cherry; D Baltimore
Journal:  Immunity       Date:  1997-07       Impact factor: 31.745

Review 5.  How proteolysis drives the cell cycle.

Authors:  R W King; R J Deshaies; J M Peters; M W Kirschner
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

Review 6.  Initiation of V(D)J recombinations in a cell-free system by RAG1 and RAG2 proteins.

Authors:  D C van Gent; J F McBlane; D A Ramsden; M J Sadofsky; J E Hesse; M Gellert
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

Review 7.  The cell cycle and V(D)J recombination.

Authors:  S Desiderio; W C Lin; Z Li
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

8.  Formation and resolution of double-strand break intermediates in V(D)J rearrangement.

Authors:  D A Ramsden; M Gellert
Journal:  Genes Dev       Date:  1995-10-01       Impact factor: 11.361

9.  Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps.

Authors:  J F McBlane; D C van Gent; D A Ramsden; C Romeo; C A Cuomo; M Gellert; M A Oettinger
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

10.  The half-life of RAG-1 protein in precursor B cells is increased in the absence of RAG-2 expression.

Authors:  U Grawunder; D G Schatz; T M Leu; A Rolink; F Melchers
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.